CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 262,500 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 445,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 337,500 shares (grant or award)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 8-K Event Auditor change
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- FWP Offering Free Writing Prospectus
Page 27 of 46 · 907 filings